Literature DB >> 3999823

[Myoclonic and convulsive encephalopathy caused by bismuth. Usefulness of dimercaprol treatment].

S Nogué, A Mas, A Parés, P Nadal, A Bertrán, M Torra, M Bachs, R Blesa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3999823

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN： 0025-7753            Impact factor:   1.725


× No keyword cloud information.
  4 in total

1.  D-penicillamine does not increase urinary bismuth excretion in patients treated with tripotassium dicitrato bismuthate.

Authors:  C U Nwokolo; R E Pounder
Journal:  Br J Clin Pharmacol       Date:  1990-10       Impact factor: 4.335

Review 2.  Drug-induced movement disorders.

Authors:  F J Jiménez-Jiménez; P J García-Ruiz; J A Molina
Journal:  Drug Saf       Date:  1997-03       Impact factor: 5.606

Review 3.  Drug-induced myoclonus: frequency, mechanisms and management.

Authors:  Félix Javier Jiménez-Jiménez; Inmaculada Puertas; María de Toledo-Heras
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 4.  Pharmacokinetics and toxicity of bismuth compounds.

Authors:  A Slikkerveer; F A de Wolff
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Sep-Oct
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.